Redefining MTM in the Post-health Reform Era

The healthcare industry has hit a crossroads that requires a strategic choice regarding the most effective allocation and use of clinical pharmacy resources on the path to performance improvement. As value-based care models drive the need for greater collaboration across clinical settings, the critical role of pharmacy expertise is heightened to accommodate a greater focus on ensuring medication effectiveness and minimizing potential for medication-related harm — a national crisis that has become the focal point of the risk-bearing regulatory landscape.

Download White Paper

You may also like:

Blog Post

NCPDP, the standards development organization focused on the pharmacy sector, just wrapped up its annual business and technology conference, which immediately followed its quarterly technical ...

View Blog Post
Blog Post

Opioid analgesics remain the first-line treatment for moderate-to-severe acute pain in emergency departments. But a study published in JAMA 2017 showed tha...

View Blog Post
Blog Post

While studies confirm that prescription drug monitoring programs (PDMPs) do help states reduce misuse and diversion of opioid drug products, many professionals and research data still report variable benefits, inconsistent usag...

View Blog Post

RxPerts Academy

Stay in the Know

Sign up to start receiving notifications via email of our upcoming webinars!

Sign Up